To fill this gap, in this follow-up study we set out to explore the difference of hepcidin, iron metabolism markers and IL-6 between obese and not obese adolescents, and to identify associations with inflammation, atherogenic dyslipidemia, IR and visceral fat. The gene discussed is IL6; the disease is metabolic syndrome.